Bioethics and European Union: the Advanced Therapy. Medicinal Products’ Case

Aurélie Mahalatchimy

Abstract


Advanced Therapy Medicinal Products (ATMP) are medicinal products which are based on human genes, cells and tissues. They are completely framed by European Union Law. They are covered by the European pharmaceutical general legislation and by a lex specialis: the regulation (EC) N°1394/2007 on ATMP. This legal framework has been accompanied with the adoption of many guidelines related to ATMP. Furthermore, ATMP raised important ethical questions which can not be ignored: human cloning, research on embryonic stem cells, chimeras … They principally come from the legal difference between the human body and its elements and the products derived from them or containing them.

Full Text:

PDF

Refbacks

  • There are currently no refbacks.




Creative Commons License

Open Access© 2012 Lider-Lab Scuola Superiore S.Anna
Except where otherwise noted, this work is licensed under a Creative Commons Attribution 3.0 Italy License. This is an Open Access journal.